Thread regarding GlaxoSmithKline PLC layoffs

Another acquisition, another opportunity for layoffs

GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.

GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to acquire Affinivax, Inc. (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1 billion upfront payment and up to $1.2 billion in potential development milestones. Affinivax is pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines.

| 948 views | | no replies yet
Post ID: @OP+1h0Qi2Kd

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply